These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31059732)

  • 1. Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop.
    Andersen ME; Gentry PR; Swenberg JA; Mundt KA; White KW; Thompson C; Bus J; Sherman JH; Greim H; Bolt H; Marsh GM; Checkoway H; Coggon D; Clewell HJ
    Regul Toxicol Pharmacol; 2019 Aug; 106():210-223. PubMed ID: 31059732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to evaluating the toxicity and carcinogenicity of man-made fibers: summary of a workshop held November 11-13, 1991, Durham, North Carolina.
    McClellan RO; Miller FJ; Hesterberg TW; Warheit DB; Bunn WB; Kane AB; Lippmann M; Mast RW; McConnell EE; Reinhardt CF
    Regul Toxicol Pharmacol; 1992 Dec; 16(3):321-64. PubMed ID: 1293648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formaldehyde carcinogenicity research: 30 years and counting for mode of action, epidemiology, and cancer risk assessment.
    Swenberg JA; Moeller BC; Lu K; Rager JE; Fry RC; Starr TB
    Toxicol Pathol; 2013 Feb; 41(2):181-9. PubMed ID: 23160431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of the Federal Panel on Formaldehyde.
    Environ Health Perspect; 1982 Feb; 43():139-68. PubMed ID: 6977445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysis.
    Rhomberg LR; Bailey LA; Goodman JE; Hamade AK; Mayfield D
    Crit Rev Toxicol; 2011 Aug; 41(7):555-621. PubMed ID: 21635189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using mechanistic information to support evidence integration and synthesis: a case study with inhaled formaldehyde and leukemia.
    Gentry R; Thompson CM; Franzen A; Salley J; Albertini R; Lu K; Greene T
    Crit Rev Toxicol; 2020 Nov; 50(10):885-918. PubMed ID: 33538218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report on the Consensus Workshop on Formaldehyde.
    Environ Health Perspect; 1984 Dec; 58():323-81. PubMed ID: 6525992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six years after the NRC review of EPA's Draft IRIS Toxicological Review of Formaldehyde: Regulatory implications of new science in evaluating formaldehyde leukemogenicity.
    Mundt KA; Gentry PR; Dell LD; Rodricks JV; Boffetta P
    Regul Toxicol Pharmacol; 2018 Feb; 92():472-490. PubMed ID: 29158043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent transitions in mechanisms of toxicity.
    Slikker W; Andersen ME; Bogdanffy MS; Bus JS; Cohen SD; Conolly RB; David RM; Doerrer NG; Dorman DC; Gaylor DW; Hattis D; Rogers JM; Setzer RW; Swenberg JA; Wallace K
    Toxicol Appl Pharmacol; 2004 Dec; 201(3):203-25. PubMed ID: 15582645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting directions and directives on hazard identification for formaldehyde carcinogenicity.
    Rhomberg LR
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):829-33. PubMed ID: 26493002
    [No Abstract]   [Full Text] [Related]  

  • 11. Human exposure to chemical mixtures: Challenges for the integration of toxicology with epidemiology data in risk assessment.
    Hernández AF; Tsatsakis AM
    Food Chem Toxicol; 2017 May; 103():188-193. PubMed ID: 28285934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workshop report: identifying key issues underpinning the selection of linear or non-linear dose-response extrapolation for human health risk assessment of systemic toxicants.
    Pottenger LH; Becker RA; Moran EJ; Swenberg JA
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):503-10. PubMed ID: 21256913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
    McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
    Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal tissue dosimetry-issues and approaches for "Category 1" gases: a report on a meeting held in Research Triangle Park, NC, February 11-12, 1998.
    Andersen ME; Jarabek AM
    Inhal Toxicol; 2001 May; 13(5):415-35. PubMed ID: 11295871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formaldehyde and leukemia: an improbable causal relationship.
    Cole P; Axten C
    Regul Toxicol Pharmacol; 2004 Oct; 40(2):107-12. PubMed ID: 15450714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing 21st-Century Risk Assessments with 21st-Century Science.
    Birnbaum LS; Burke TA; Jones JJ
    Environ Health Perspect; 2016 Apr; 124(4):A60-3. PubMed ID: 27035154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation modeling of the tissue disposition of formaldehyde to predict nasal DNA-protein cross-links in Fischer 344 rats, rhesus monkeys, and humans.
    Conolly RB; Lilly PD; Kimbell JS
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():919-24. PubMed ID: 11036001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epidemiology in health risk assessment.
    Krewski D; Wigle D; Clayson DB; Howe GR
    Recent Results Cancer Res; 1990; 120():1-24. PubMed ID: 2236869
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.